CRISM Therapeutics is a pharmaceutical company that develops ChemoSeed to improve the clinical performance of cancer treatments.
CRISM Therapeutics has raised $1.3M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in December 2025.
CRISM Therapeutics is headquartered in Tórtola, Spain.
CRISM Therapeutics is a pharmaceutical company that develops ChemoSeed to improve the clinical performance of cancer treatments.
CRISM Therapeutics is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"CRISM Therapeutics — Funding & Investors." VCBacked, December 10, 2025, https://www.vcbacked.co/company/crism-therapeutics. Accessed August 17, 2026.
VCBacked. (2025). CRISM Therapeutics — Funding & Investors. Retrieved August 17, 2026, from https://www.vcbacked.co/company/crism-therapeutics
{{cite web |title=CRISM Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/crism-therapeutics |website=VCBacked |access-date=August 17, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated